RUO Enforcement Begins?

Friday, September 30, 2011

"Even though your device is labeled RU[O], you are labeling it and promoting it for nonresearch clinical diagnosis without clearance or approval in violation of the Act. ... These statements suggest the clinical utility of the device and instruct clinicians on the use of this device to detect and diagnose disease. ... These are diagnostic claims that indicate that the device is intended for clinical in vitro diagnostic use, and not for research use only."
— FDA Warning Letter, 9/14/11

I could be wrong, but I think this warning letter might be the first one issued under the rubric of the recent RUO draft guidance. Whether it is the first or not, one thing is clear: the gauntlet has been thrown.

I don't know any more about this specific case than what's posted online. I think it's safe to say we're going to be advising some of our clients to take another look at their risk assessments.

Tags: 510(k), Enforcement, FDA, IVD, PMA, RUO, Warning Letters

Other Blog Authors

Dylan Reinhardt
Dave Kern
Steve Gutman
Jo-Ann Gonzales

Recent Blog Posts

The Staple That Changed an Industry LDT regulation and the perils of challenging Eminem to a rap battle
FDA Releases the Kraken Whichever way this breaks, it's long past time to have this conversation in a meaningful way
Illumina Acquires Myraqa Acquisition Strengthens Illumina’s Clinical Readiness
The Spirit of GLP A Best Practice for IVDs
Process Performance Qualification (PPQ) Lots So, how many lots are required?
The Case for Risk-based Monitoring Better the devil you know...
Form Follows Function OIR Reorganizes to Meet the Advancing Wave of Molecular Diagnostics
CDRH Unveils New PMA Guidance Documents Attention shoppers, it's two-for-one day!